Dose
amount of a drug administered to an organism
Concentration
amount of drug in a given compartment
Efficacy
the maximal effect produced by the drug
true
Not all drugs reach 100% effect in the system, but they still reach their Emax. T/f?
EC50
the concentration of a drug that produces 50% of its maximal effect
Potency
the concentration/dose required to produce an effect of a given intensity
Affinity
measure of the strength and probability that a drug will bind an available receptor at a given time
Kd
the equilibrium dissociation constant when half of the drug is bound and the other half is unbound.
B max
the maximal amount of receptors bound by drug at plateau
Kd
Which is usually greater? EC50 or Kd
high affinity
What does low kd signify ?
drug affinity, degree of spareness
Why aren't EC50 and Kd always the same?
Degree of spareness
the total # of receptors present vs total # of receptors needed to elicit Emax
coupling
What ties drug binding to the end effect?
Complex
Is coupling usually simple or complex?
Spare receptors
when an Emax is reached but there are still receptors left unbinded
Intermediate activation
maximal effect elicited by activation of relatively few receptors because the response initiated by an individual drug-receptor binding event persists longer than the binding event itself.
can't be activated
The receptor is available for drug binding, however, intermediate activation is taken place; this means downstream signaling ________
true
Spare receptors dramatically influence Kd. T/F?
10
If your EC50 is 10 and you have 10 receptors, what is your Kd?
less efficient
Partial agonists are ______ couplers
by binding a partial agonist
How can we inhibit the response of a full agonist clinically?
Inverse Agonist
-receptors can be in active form (Ra) or inactive form (Ri)
-shift equilibrium to Ri
Agonist
-receptors can be in active form (Ra) or inactive form (Ri)
-shift equilibrium to Ra
Competitive antagonist
-block transition to Ra by competing for orthosteric site
-can be overcome with increasing [agonist], thereby shifting potency (EC50)
Noncompetitive antagonist
-block transition to Ra by binding to an allosteric site
-cannot be overcame by increased [agonist], thereby shifting efficacy (Emax)
false
All drugs are either agonists or antagonists. T/F
drug affinity; degree of spareness
Why aren't EC50 and Kd always the same?
coupling
______ is what ties drug binding to the end effect
Kd=EC50
If you have 10 receptors, Kd is 10.
If no spare receptors exist,
Partial agonists
-receptors that produce a lower effect at full receptor occupancy
true
Partial agonists can competitively inhibit the responses of a full agonist. True or false?
prevents endogenous ligand/agonist binding to Ri
What is antagonists role in Ra and Ri equilibrium?
block transition; orthosteric site
Competitive antagonists ________ to Ra by competing for the ________
block transition; allosteric site
Noncompetitive antagonists _______ to Ra by binding to an __________
c
Which type of antagonists can be overcame with increasing agonist? Which cannot?
a. competitive; uncompetitive
b. noncompetitive; competitive
c. competitive; noncompetitive
Ki
-this measuring factor utilizes the ratio of a known concentration of antagonist and compares it to an agonist without antagonist present vs with antagonist present.
-defines the strength of competitive antagonist
false
All drugs are either agonist or antagonist. True or false?
voltage-gated, transporters, enzymes
Which type of receptors don't respond to typical ligand binding interactions?